Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Chinese economy to provide more opportunities for cooperation




BEIJING, March 13, 2024 /PRNewswire/ — A report from People’s Daily:

The international community is closely watching China’s “two sessions,” the annual gatherings of the National People’s Congress (NPC) and the Chinese People’s Political Consultative Conference (CPPCC) National Committee. It is optimistic about China’s potential for economic and social development, looking forward to China injecting more positive energy into world economic recovery.

It is widely believed that the GDP growth target of around 5 percent reflects China’s confidence in its economy, and the new quality productive forces will contribute to the country’s high-quality development and advancing Chinese modernization. With stable economic growth and a vast market, cooperating with China has become a highly attractive choice.

In 2023, China’s economy showed strong resilience and achieved remarkable results. Despite the complex international environment and challenging tasks to stabilize reform and development, China has accomplished its main economic and social development goals for the year.

In 2023, the country’s GDP grew 5.2 percent year-on-year to over 126 trillion yuan ($17.53 trillion), a growth rate that ranks among the top of the world’s major economies.

As calculated at comparable prices, China’s economic increment last year exceeded 6 trillion yuan, equivalent to the economic aggregate of a medium-sized country. This proves that China’s economy remains a crucial engine for global economic growth and possesses immense development potential.

The 2024 growth target of around 5 percent highlights the stability of China’s economy, sending a clear and positive signal. The stable growth expectation of China not only helps consolidate consensus on development but also provides valuable certainty for the sluggish global economy.

China has significant institutional advantages, the demand advantage from an ultra-large market, the supply advantage of a well-established industrial system, and the talent advantage of a large number of skilled laborers. Its technological innovation capabilities continue to improve, while new industries, business models, and growth drivers are rapidly growing. Its endogenous growth momentum is also being generated. The overall trend of recovery and long-term improvement remains unchanged and will not change.

China’s economy is becoming “newer” as new growth drivers and advantages for development are constantly forged.

Developing new quality productive forces is an endogenous requirement and a pivot of high-quality development. Accelerating the development of new quality productive forces will undoubtedly provide stronger impetus and support for high-quality development.

The inclusion of “new quality productive forces” in this year’s government work report has attracted widespread attention from the international community, with many recognizing the term as the strategic cornerstone for China to empower economic development through innovation and technological progress.

Last year, China’s exports of electric vehicles, lithium-ion batteries, and photovoltaic products exceeded 1 trillion yuan, with a nearly 30 percent year-on-year growth. The digital economy accelerated its development, with over half of the country’s population becoming 5G users. The installed capacity of renewable energy historically surpassed that of thermal power, with the annual new installation exceeding half of the global.

Traditional industries underwent rapid transformation and upgrading, while strategic emerging industries flourished. The future industries were laid out orderly, with advanced manufacturing and modern services deeply integrated. Several major industrial innovations have reached the international advanced level, marking significant progress in the construction of China’s modern industrial system.

China’s economy is releasing its vitality and potential through high-level opening up, aiming for mutual benefits with other countries. China actively aligns with high-standard international economic and trade rules, steadily expands institutional opening up, promotes quality and quantity of foreign trade, increases efforts to attract foreign investment, and advances high-quality Belt and Road cooperation. It is also deepening both bilateral and regional economic cooperation.

Through a series of practical measures, the country has enhanced the synergy between the domestic and international markets and resources, sending a clear signal that China is firmly committed to expanding high-level opening up.

International investors continue to see great opportunities for investing in China, with many multinational companies agreeing that to maintain global competitiveness, it is necessary to increase their presence in the Chinese market.

China is persistently advancing high-level opening up, which not only drives its own economic development but also provides win-win opportunities for global players, which contributes to the growth of the global economy as a whole.

In the past year, China faced an array of interwoven difficulties and challenges. China’s economy grew in wave-like progress, moving forward amid twists and turns. Indeed, these achievements did not come easily.

In the new year, China will set its goals, make concrete efforts, and continue to effectively upgrade the quality and appropriately expand the quantity of the national economy. It will constantly bring new impetus and new opportunities to the world through its own new development.

View original content:

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024




STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision,c3956826

The following files are available for download:

Invitation to presentation of EQT AB’s Q1 Announcement 2024,c3285895

EQT AB Group


View original content:

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs



  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo –

Cision View original content to download multimedia:

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update




VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (, a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit and connect with us on X and LinkedIn.


Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo –

Cision View original content:

Continue Reading